Here's Why Labcorp Holdings (LH) is a Strong Value Stock

Company Overview - Labcorp Holdings, headquartered in Burlington, NC, is a leading healthcare diagnostics company that provides comprehensive clinical laboratory services and end-to-end drug development support [12] - In 2015, Labcorp acquired Covance, a drug development services company that offers a wide range of early-stage and late-stage product development services primarily to the pharmaceutical and biotechnology industries [12] Investment Ratings - Labcorp is currently rated as a 3 (Hold) on the Zacks Rank, with a VGM Score of A, indicating a solid overall performance [13] - The company has a Value Style Score of B, supported by attractive valuation metrics such as a forward P/E ratio of 16.64, which may appeal to value investors [13] Earnings Estimates - In the last 60 days, eight analysts have revised their earnings estimates upwards for fiscal 2025, with the Zacks Consensus Estimate increasing by $0.25 to $16.30 per share [13] - Labcorp has demonstrated an average earnings surprise of +2.5%, indicating a positive trend in earnings performance [13] Investment Potential - With a solid Zacks Rank and top-tier Value and VGM Style Scores, Labcorp is recommended to be on investors' short list for potential investment opportunities [14]